Evidence Library
Filter by drug, type, year, and open access.
Showing 1–3 of 3 results
- The ASAM Clinical Practice Guideline on Alcohol Withdrawal Management — Journal of Addiction Medicine (2020)• Drug: oxazepamDOI
- ASAM guideline on benzodiazepine tapering and prescribing — Journal of Addiction Medicine (2020)• Drug: oxazepamDOI
- FDA boxed warning update for benzodiazepines (abuse, addiction, dependence, withdrawal) — FDA Drug Safety Communication (2020)• Drug: oxazepamOpen access
